The Opportunity:
As VP Global Head of Biosimilars, you will be responsible for TEVA Biosimilar business strategy. This pivotal role will optimize our existing portfolio, secure our pipeline and work with our commercial regions and markets in the execution of our biosimilar offering to meet our revenue expectations.
This opportunity will take ownership of devising distinctive strategies that empower Teva to extract the utmost value and produce best in class Biosimilars. This will require crafting, cultivating and leveraging critical insights along the patient journey, healthcare provider network, payer landscape, market access avenues and private label, wholesaler, hospital and retail channels. A strategic roadmap for launch planning, as well as a comprehensive data dashboard, will be meticulously developed to ensure the maximization of asset value at each juncture of their lifecycle.
Working within a matrix environment, effectively engineering internal cross-functional alignment will be a core objective working with BD, R and D, Alliance Management, GSC, other global functions and the local country affiliates. In addition, the role will require working with 3rd party partners to ensure the portfolio is developed and launched on time and in full.
In essence, the Head of Biosimilars will be at the helm of a multifaceted enterprise, navigating through the intricacies of strategy, collaboration, and decision-making to drive Teva's biosimilar business to unprecedented heights of success.
This role can be based in Europe, Israel or Parsippany USA
Key Responsibilities:
Give direction to our BD activities in alignment with the biosimilar strategy, including supporting alliance management and management of our partnerships.
Manage and produce internal financial projections and scenarios to bolster pipeline and portfolio strategy, while building global GTN (Gross-to-Net) and other financial targets.
Work with the Regions to develop GTM (Go to Market) strategies and be a partner in launch tactics and market execution
Devise a comprehensive data strategy that converges into a singular panoramic view of commercial performance.
Forge unity across the board, leveraging a wealth of experience and strong understanding of global portfolio prerequisites for asset valuation and selection.
Execute thorough due diligence in both product and process development, analytical advancement, and characterization.
Harmonize due diligence endeavors with both internal stakeholders and external consultants, particularly in the realms of clinical development and regulatory strategy.
Author effective diligence documents and manage the records and reports generated by internal/ external input.
Work with internal development partners including clinical, regulatory, and TEVA internal operations to develop and bring these products to market.
Review and align on the development of the regulatory submission approach in collaboration with Regulatory Affairs to coordinate the delivery of submission documentation as needed.
Sustain an up-to-date mastery of technologies and regulatory frameworks, remaining in sync with the evolving requisites for the development of biological/biosimilar products.
